Nonalcoholic Fatty Liver Disease Screening in Type 2 Diabetes Mellitus Patients in the Primary Care Setting - Vieira Barbosa - 2021 - Hepatology Communications - Wiley Online Library
Non-Alcoholic Fatty Liver Diagnosis - Viral Hepatitis and Liver Disease
Improvement of non-invasive tests of liver steatosis and fibrosis as indicators for non-alcoholic fatty liver disease in type 2 diabetes mellitus patients with elevated cardiovascular risk profile using the PPAR-α/γ agonist aleglitazar
Formulas of HSI, FLI and FIB-4 indexes. | Download Scientific Diagram
Cureus | Assessment of Liver Fibrosis Using Non-invasive Screening Tools in Individuals With Diabetes Mellitus and Metabolic Syndrome
Cost-comparison analysis of FIB-4, ELF and fibroscan in community pathways for non-alcoholic fatty liver disease | BMC Gastroenterology | Full Text
Why are non-invasive risk scores such as FIB-4 used in clinical practice? | Liver Fellow Network
The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool? - ScienceDirect
Fib-4 at Fatty Liver Foundation
FIB-4 Index - Fatty Liver Foundation
FIB-4 Calculator | Liver Fibrosis Score Calculator
Subgroup analysis based on different FIB-4 index cutoff values. | Download Table
Cureus | Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
Jaundice & Liver Disease – GP Gateway
Core Concepts - Evaluation and Staging of Liver Fibrosis - Evaluation, Staging, and Monitoring of Chronic Hepatitis C - Hepatitis C Online
FIB‐4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine‐Gray competing risk analysis - Schreiner - Liver International - Wiley Online Library
Identifying High-Risk NASH Patients: What We Know so Far | HMER
Figure 4 from Evaluation and Staging of Liver Fibrosis | Semantic Scholar
FIB-4 Calculator | Liver Fibrosis Score Calculator
Scott Isaacs on Twitter: "Identify patients at high-risk for #NAFLD and use the FIB-4 index for fibrosis risk stratification. For indeterminate risk, use elastography or serum biomarkers as a second #NIT. @TheAACE @
IJMS | Free Full-Text | Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives
Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients - ScienceDirect
Why are non-invasive risk scores such as FIB-4 used in clinical practice? | Liver Fellow Network
